Lv3
389 积分 2022-07-13 加入
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
16天前
已关闭
Iptacopan in IgA Nephropathy - Final 24-Month Data
2个月前
已完结
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
3个月前
已完结
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
7个月前
已完结
Targeting inflammation to treat diabetic kidney disease: the road to 2030
9个月前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents A Phase 3 Randomized Clinical Trial
9个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
10个月前
已完结
皖公网安备34019202002308
